Abstract
Epistaxis in patients on antiplatelet and anticoagulant therapy is common and typically benign. We present a case of a rare nasal septal malignancy in a patient on antiplatelet therapy and discuss worrisome symptoms and signs which should prompt early referral to a specialist.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 411-413 |
| Number of pages | 3 |
| Journal | American Journal of Otolaryngology - Head and Neck Medicine and Surgery |
| Volume | 35 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jan 1 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Epistaxis in a patient on antiplatelet therapy: Not always benign'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS